HRTX R&D Expense Growth
Heron Therapeutics Inc · R&D Expense Growth
HRTX R&D Expense Growth
Latest reported-25.50%period ending
HRTX FY R&D Growth (YoY) (0.00% → -25.50%)
Latest values, visible window
High-resolution chart · PNG
HRTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -25.499% | |
| -57.3685% | |
| -52.6831% | |
| -36.7808% | |
| -25.0451% | |
| 4.2723% | |
| 19.5313% | |
| 1.0463% | |
| 34.3825% | |
| 68.5517% | |
| 11.5806% | |
| 67.2758% | |
| 117.8797% | |
| 83.3191% | |
| 12.9818% | |
| -6.824% | |
| -60.0349% | |
| 0.7385% | |
| 27.0937% | |
| 47.9367% | |
| -10.4045% | |
| 32.7367% | |
| 29.273% | |
| -8.8323% | |
| 97.8993% | |
| -13.6512% | |
| -2.2727% | |
| 18.9189% | |
| 5.7143% | |
| -14.6341% | |
| -34.9206% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |